Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CHRS Coherus Biosciences

休市中 10-16 16:00:00 EDT

0.9900

-0.0800

-7.48%

盘后1.02

+0.0300+3.03%

19:30 EDT

最高1.07	最低0.9868	成交量93.85万
今开1.07	昨收1.07	日振幅7.78%
总市值1.53亿	流通市值1.35亿	总股本1.54亿
成交额95.14万	换手率0.69%	流通股本1.36亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CHRS","market":"US","secType":"STK","nameCN":"Coherus Biosciences","latestPrice":0.99,"timestamp":1792180800000,"preClose":1.07,"halted":0,"volume":938500,"hourTrading":{"tag":"盘后","latestPrice":1.02,"preClose":0.99,"latestTime":"19:30 EDT","volume":6877,"amount":6864.33,"timestamp":1792193404136,"change":0.03,"changeRate":0.030303,"amplitude":0.030303},"delay":0,"changeRate":-0.07476635514018698,"floatShares":136000000,"shares":154217609,"eps":-1.001087,"marketStatus":"休市中","change":-0.08,"latestTime":"10-16 16:00:00 EDT","open":1.07,"high":1.07,"low":0.98675,"amount":951353.22675,"amplitude":0.077804,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.001087,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1792396800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1415250000000,"exchange":"NASDAQ","adjPreClose":1.07,"postHourTrading":{"tag":"盘后","latestPrice":1.02,"preClose":0.99,"latestTime":"19:30 EDT","volume":6877,"amount":6864.33,"timestamp":1792193404136,"change":0.03,"changeRate":0.030303,"amplitude":0.030303},"volumeRatio":0.639685,"impliedVol":4.069,"impliedVolPercentile":0.9562},"requestUrl":"/m/hq/s/CHRS","defaultTab":"news","newsList":[{"id":"1159336537","title":"Coherus肿瘤部门终止2026年1月招股书及销售协议下的持续发行——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1159336537","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159336537?lang=zh_cn&edition=full","pubTime":"2026-08-29 04:36","pubTimestamp":1787949369,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）文件显示，Coherus肿瘤部门已正式终止依据2026年1月招股书及销售协议框架下的持续发行计划。这一决定标志着该公司此前推进的阶段性融资安排画上句号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHRS","BK4139","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130061966","title":"Coherus BioSciences：公司将供应Loqtorzi；Zumutor将赞助一期临床试验；双方均保留商业权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1130061966","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130061966?lang=zh_cn&edition=full","pubTime":"2026-06-24 02:03","pubTimestamp":1782237794,"startTime":"0","endTime":"0","summary":"Coherus BioSciences宣布，公司将负责供应其药物Loqtorzi。与此同时，Zumutor将赞助一项关于该药物的第一阶段临床试验。根据协议条款，双方均将保留各自相关的商业权利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CHRS","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115522503","title":"Coherus与Zumutor Biologics宣布临床合作，评估Zm008联合Loqtorzi®（托瑞普利单抗-tpzi）的疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1115522503","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115522503?lang=zh_cn&edition=full","pubTime":"2026-06-24 02:01","pubTimestamp":1782237675,"startTime":"0","endTime":"0","summary":"Coherus BioSciences与Zumutor Biologics已宣布一项临床合作，旨在评估Zm008与Loqtorzi®（托瑞普利单抗-tpzi）联合使用的潜力。这项合作将聚焦于探索该联合疗法在特定适应症中的安全性与有效性，标志着两家公司在肿瘤免疫治疗领域迈出的重要一步。通过结合各自的专长与创新资产，双方期望能为患者带来新的治疗选择，并加速相关临床开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4535","CHRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145605744","title":"Coherus Oncology第一季度销售额为1231万美元，低于IBES预估的1430万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145605744","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145605744?lang=zh_cn&edition=full","pubTime":"2026-05-12 04:32","pubTimestamp":1778531524,"startTime":"0","endTime":"0","summary":"Coherus BioSciences公布的第一季度财务数据显示，其销售额为1231万美元，未能达到市场普遍预期的1430万美元。与此同时，公司经调整后的净亏损达到3392.5万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","CHRS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518783267","title":"Coherus BioSciences(CHRS.US)：2024年Q4财报实现营收5414.4万美元，前值为9152.4万美元，预期值为4388万美元；每股收益为-0.28美元，前值为-0.62美元，预期值为-0.13美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518783267","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518783267?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:31","pubTimestamp":1741638703,"startTime":"0","endTime":"0","summary":"Coherus BioSciences(CHRS.US)：2024年Q4财报实现营收5414.4万美元，前值为9152.4万美元，预期值为4388万美元；每股收益为-0.28美元，前值为-0.62美元，预期值为-0.13美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11043148642742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CHRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109189574","title":"Coherus BioSciences 2024年第四季度调整后每股亏损$(0.28)，不及预期$(0.13)，销售额$5414.4万超过预期$4727.0万","url":"https://stock-news.laohu8.com/highlight/detail?id=1109189574","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109189574?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:18","pubTimestamp":1741637918,"startTime":"0","endTime":"0","summary":"Coherus BioSciences  报告季度每股亏损$，低于分析师一致预期的$，减少了115.38%。与去年同期每股亏损$相比，这是一个54.84%的改善。公司报告季度销售额为$5414.4万，超过分析师一致预期的$4727.0万，高出14.54%。以上内容来自Benzinga Earnings专栏，原文如下：Coherus BioSciences  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 115.38 percent. This is a 54.84 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $54.144 million which beat the analyst consensus estimate of $47.270 million b","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Coherus BioSciences 2024年第四季度调整后每股亏损$(0.28)，不及预期$(0.13)，销售额$5414.4万超过预期$4727.0万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518227963","title":"Coherus Biosciences, Inc.盘中异动 早盘股价大涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518227963?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:43","pubTimestamp":1741614197,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时43分，Coherus Biosciences, Inc.股票出现异动，股价急速拉升5.77%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2346.37%、549.18%、83.46%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、28.59%、25.35%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021431798a29fe7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021431798a29fe7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517319875","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.28%报0.976美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517319875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517319875?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:20","pubTimestamp":1741281608,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时20分，Coherus Biosciences, Inc.股票出现波动，股价急速下跌5.28%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307012008989ed2d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307012008989ed2d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517698570","title":"Coherus Biosciences, Inc.盘中异动 股价大涨5.47%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517698570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517698570?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:03","pubTimestamp":1741118611,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时03分，Coherus Biosciences, Inc.股票出现波动，股价快速上涨5.47%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305040331989bf850&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305040331989bf850&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","CHRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516654568","title":"Coherus Biosciences, Inc.盘中异动 大幅跳水5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516654568?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:10","pubTimestamp":1741025425,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时10分，Coherus Biosciences, Inc.股票出现波动，股价急速跳水5.41%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021026a25d7f84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021026a25d7f84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514750043","title":"Coherus Biosciences, Inc.盘中异动 快速拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514750043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514750043?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:32","pubTimestamp":1740756734,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时32分，Coherus Biosciences, Inc.股票出现波动，股价快速拉升5.09%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228233214989687b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228233214989687b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514987776","title":"Coherus Biosciences, Inc.盘中异动 临近午盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514987776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514987776?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:36","pubTimestamp":1740414967,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时36分，Coherus Biosciences, Inc.股票出现波动，股价急速上涨5.14%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。该公司在美国销售 Neulasta 的生物仿制药，UDENYCA，并预计于 2023 年在美国推出 FDA 批准的 Humira 生物仿制药 YUSIMRY。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225003608962eb475&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225003608962eb475&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512810254","title":"Coherus Biosciences, Inc.盘中异动 早盘急速跳水5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512810254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512810254?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:05","pubTimestamp":1739981106,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时05分，Coherus Biosciences, Inc.股票出现异动，股价大幅下挫5.36%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000506a24c0d6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000506a24c0d6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512931101","title":"Coherus Biosciences, Inc.盘中异动 大幅下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512931101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512931101?lang=zh_cn&edition=full","pubTime":"2025-02-19 02:10","pubTimestamp":1739902251,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日02时10分，Coherus Biosciences, Inc.股票出现异动，股价大幅下挫5.00%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。其相关个股中，Aditxt, Inc.、Solid Biosciences Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为652.29%、197.44%、164.02%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021051a24adaa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021051a24adaa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510532973","title":"Coherus Biosciences, Inc.盘中异动 下午盘大幅下挫5.13%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510532973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510532973?lang=zh_cn&edition=full","pubTime":"2025-02-12 02:32","pubTimestamp":1739298734,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日02时32分，Coherus Biosciences, Inc.股票出现异动，股价急速下挫5.13%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.79%。其相关个股中，Omega Therapeutics, Inc.、Lipella Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为3092.34%、1432.04%、482.65%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为143.33%、72.23%、58.60%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212023214a2422ead&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212023214a2422ead&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510089496","title":"Coherus Biosciences, Inc.盘中异动 大幅拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510089496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510089496?lang=zh_cn&edition=full","pubTime":"2025-02-11 03:56","pubTimestamp":1739217413,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日03时56分，Coherus Biosciences, Inc.股票出现异动，股价大幅上涨5.36%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211035653abc9ea01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211035653abc9ea01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509789794","title":"Coherus Biosciences, Inc.盘中异动 急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509789794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509789794?lang=zh_cn&edition=full","pubTime":"2025-02-07 04:54","pubTimestamp":1738875267,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日04时54分，Coherus Biosciences, Inc.股票出现异动，股价快速下跌5.00%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207045427961a4ff7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207045427961a4ff7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509906287","title":"Coherus Biosciences, Inc.盘中异动 早盘大幅拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509906287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509906287?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:02","pubTimestamp":1738767742,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时02分，Coherus Biosciences, Inc.股票出现波动，股价急速上涨5.17%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.59%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020523022296190ed7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020523022296190ed7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508457652","title":"Coherus Biosciences, Inc.盘中异动 急速拉升5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508457652?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:33","pubTimestamp":1738679605,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时33分，Coherus Biosciences, Inc.股票出现波动，股价快速拉升5.41%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Azitra Inc、Evaxion Biotech As、Invivyd, Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为920.51%、691.29%、186.98%，振幅较大的相关个股有Azitra Inc、Invivyd, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为35.91%、19.81%、19.74%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223325a2392939&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223325a2392939&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508996742","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508996742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508996742?lang=zh_cn&edition=full","pubTime":"2025-02-01 00:24","pubTimestamp":1738340683,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日00时24分，Coherus Biosciences, Inc.股票出现异动，股价大幅下跌5.17%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.57%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502010024439614f89c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502010024439614f89c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.coherus.com","stockEarnings":[{"period":"1week","weight":-0.0748},{"period":"1month","weight":-0.1885},{"period":"3month","weight":-0.2929},{"period":"6month","weight":-0.5},{"period":"1year","weight":-0.4211},{"period":"ytd","weight":-0.3028}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Coherus Oncology, Inc.于2010年9月在特拉华州注册成立。该公司是一家商业阶段的生物制药公司，专注于创新癌症治疗的研究、开发和商业化以及已获批准的生物类似物组合的商业化。该公司的战略是建立一个领先的免疫肿瘤专营权，其资金来自通过净销售美国食品和药物管理局批准的疗法的多元化组合所产生的现金。","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.044108},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.013974},{"month":3,"riseRate":0.5,"avgChangeRate":0.004845},{"month":4,"riseRate":0.583333,"avgChangeRate":-0.024231},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.033789},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.026295},{"month":7,"riseRate":0.583333,"avgChangeRate":0.096538},{"month":8,"riseRate":0.75,"avgChangeRate":0.105511},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.093885},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.072542},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.005438},{"month":12,"riseRate":0.583333,"avgChangeRate":0.04063}],"exchange":"NASDAQ","name":"Coherus Biosciences","nameEN":"Coherus BioSciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Coherus Biosciences(CHRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Coherus Biosciences,CHRS,Coherus Biosciences股票,Coherus Biosciences股票老虎,Coherus Biosciences股票老虎国际,Coherus Biosciences行情,Coherus Biosciences股票行情,Coherus Biosciences股价,Coherus Biosciences股市,Coherus Biosciences股票价格,Coherus Biosciences股票交易,Coherus Biosciences股票购买,Coherus Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Coherus Biosciences(CHRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}